BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8879538)

  • 21. Butyl benzyl phthalate blocks Ca2+ signaling and catecholamine secretion coupled with nicotinic acetylcholine receptors in bovine adrenal chromaffin cells.
    Liu PS; Lin CM; Pan CY; Kao LS; Tseng FW
    Neurotoxicology; 2003 Jan; 24(1):97-105. PubMed ID: 12564386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separation of two pathways for calcium entry into chromaffin cells.
    Gandía L; Casado LF; López MG; García AG
    Br J Pharmacol; 1991 May; 103(1):1073-8. PubMed ID: 1652335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ring E analogs of methyllycaconitine (MLA) as novel nicotinic antagonists.
    Bergmeier SC; Lapinsky DJ; Free RB; McKay DB
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2263-6. PubMed ID: 10465558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by cyclothiazide of neuronal nicotinic responses in bovine chromaffin cells.
    Nooney JM; Feltz A
    Br J Pharmacol; 1995 Feb; 114(3):648-55. PubMed ID: 7735691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyamine toxins: development of selective ligands for ionotropic receptors.
    Strømgaard K; Jensen LS; Vogensen SB
    Toxicon; 2005 Mar; 45(3):249-54. PubMed ID: 15683862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor protection studies to characterize neuronal nicotinic receptors: tubocurarine prevents alkylation of adrenal nicotinic receptors.
    Free RB; McKay DB
    Brain Res; 2001 Feb; 891(1-2):176-84. PubMed ID: 11164821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative suppression of phthalate monoesters and phthalate diesters on calcium signalling coupled to nicotinic acetylcholine receptors.
    Liu PS; Tseng FW; Liu JH
    J Toxicol Sci; 2009 Jun; 34(3):255-63. PubMed ID: 19483380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus.
    Sershen H; Balla A; Lajtha A; Vizi ES
    Neuroscience; 1997 Mar; 77(1):121-30. PubMed ID: 9044380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated Ca2+ channels and Ca2+ stores.
    Dajas-Bailador FA; Mogg AJ; Wonnacott S
    J Neurochem; 2002 May; 81(3):606-14. PubMed ID: 12065669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human nicotinic receptors in chromaffin cells: characterization and pharmacology.
    Albillos A; McIntosh JM
    Pflugers Arch; 2018 Jan; 470(1):21-27. PubMed ID: 29058146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Ca2+ channel antagonists on chromaffin cell death and cytosolic Ca2+ oscillations induced by veratridine.
    Maroto R; De la Fuente MT; Artalejo AR; Abad F; López MG; García-Sancho J; García AG
    Eur J Pharmacol; 1994 Aug; 270(4):331-9. PubMed ID: 7805782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lethal effects of an insecticidal spider venom peptide involve positive allosteric modulation of insect nicotinic acetylcholine receptors.
    Windley MJ; Vetter I; Lewis RJ; Nicholson GM
    Neuropharmacology; 2017 Dec; 127():224-242. PubMed ID: 28396143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Q-type Ca2+ channels are located closer to secretory sites than L-type channels: functional evidence in chromaffin cells.
    Lara B; Gandía L; Martínez-Sierra R; Torres A; García AG
    Pflugers Arch; 1998 Mar; 435(4):472-8. PubMed ID: 9446693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors.
    Vernino S; Rogers M; Radcliffe KA; Dani JA
    J Neurosci; 1994 Sep; 14(9):5514-24. PubMed ID: 8083751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release.
    Mah SJ; Tang Y; Liauw PE; Nagel JE; Schneider AS
    Brain Res; 1998 Jun; 797(1):173-80. PubMed ID: 9630615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel.
    Zheng J; Morrisett RA; Zhu J; Hexum TD
    J Pharmacol Exp Ther; 1995 Aug; 274(2):891-7. PubMed ID: 7543575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of nicotine mediated communication between NGF-differentiated PC12 and HEL cells.
    Krjukova J; Akerman KE
    Neuroreport; 2002 Jul; 13(9):1157-61. PubMed ID: 12151760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. omega-Conotoxin GVIA blocks nicotine-induced catecholamine secretion by blocking the nicotinic receptor-activated inward currents in bovine chromaffin cells.
    Fernández JM; Granja R; Izaguirre V; González-García C; Ceña V
    Neurosci Lett; 1995 May; 191(1-2):59-62. PubMed ID: 7659292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlorpromazine-induced inhibition of catecholamine secretion by a differential blockade of nicotinic receptors and L-type Ca2+ channels in rat pheochromocytoma cells.
    Lee IS; Park TJ; Suh BC; Kim YS; Rhee IJ; Kim KT
    Biochem Pharmacol; 1999 Sep; 58(6):1017-24. PubMed ID: 10509754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release.
    Schneider AS; Nagel JE; Mah SJ
    Eur J Pharmacol; 1996 Dec; 317(2-3):R1-2. PubMed ID: 8997631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.